• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 8/28/24: Further Developing Patient Services, Building Effective Diabetes Quality Improvement Initiatives & more

News
Article

The latest news for pharma industry insiders.

Further Developing Patient Services

Meghan Mullooly, Archbow Consulting’s Vice President, outlines the various types of available digital solutions when delivering patient services, while also sharing ways to drive efficiencies.

Key Components of Building Effective Diabetes Quality Improvement Initiatives

A renowned expert examines the essential elements for developing successful diabetes quality improvement programs.

AI Regulation Is Coming. Fortune 500 Companies Are Bracing for Impact.

Some 27% of Fortune 500 companies cite AI regulation as a risk in their annual reports.

Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine

Following FDA authorization and CDC recommendation, Rite Aid announced that scheduling is now available for eligible customers seeking the updated COVID-19 (2024-2025) vaccines at its locations and at Bartell Drugs locations in the Pacific Northwest. Appointments are available immediately.

ACTO on LinkedIn

Another piece discussing how #AI will help not hurt #biopharma from Pharmaceutical Executive.

Beyond the Buzz: Gauging the True Benefits of AI Today

https://lnkd.in/gRhZBQYD

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs